跳至主要内容
临床试验/NCT06187532
NCT06187532已完成不适用

Carotid Plaque-Burden Scale and Outcomes. Improvements in Risk Stratification for Future Cardiovascular Disease by Adding to SCORE2. A Real Life Study

Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura0 个研究点目标入组 1,004 人开始时间: 2000年2月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,004
主要终点
Differences in rates of all-cause death

研究概览

简要总结

Carotid ultrasonography has been proposed as a tool for prediction of future cardiovascular disease (CVD). Nevertheless, its role in clinical practice remains controversial.

Methods: The investigators analyse the incidence of CVD and mortality in a cohort of 1004 participants without preexisting CVD according to a simple plaque scale recorded in different segments of the carotid artery assess by ultrasound. A prognostic tool for CV events was development adding Carotid Plaque-Burden (CPB) scale to the Systematic COronary Risk Evaluation (SCORE2) table (CPB- SCORE2 scale).

详细描述

Based in number of plaques and stenosis a simple plaque scale was recorded in different segments of carotid artery, involving a cohort of 1004 participants with vascular risk factors. Outcomes were recorded during 14 years. A prognostic tool for CV events was development adding simple Carotid Plaque-Burden (CPB) scale to the SCORE2 table (CPB- SCORE2 scale).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any of these vascular risk factors: Total cholesterol >200 mg/dL, hypertension, or diabetes, or receiving medication for them
  • No cardiovascular disease: coronary, cerebral o peripheral arterial disease.

排除标准

  • Associated conditions: cancer, heart failure, chronic obstructive disease, renal insufficiency, neurodegenerative diseases, rheumatic diseases or chronic infections.
  • Neck anatomical barriers to perform ultrasound.
  • Enrolled in a clinical trial.
  • Attend <70% of regular appointments

结局指标

主要结局

Differences in rates of all-cause death

时间窗: 12 year follow-up

All-cause death: number of death from any cause

Differences in rates of major adverse cardiovascular events (MACE)

时间窗: 12 year follow-up

MACE: number of Major Adverse Cardiovascular Events; myocardial infarction, ictus or amputation or revascularisation of leg due to critical ischaemia

次要结局

  • Diagnostic value of Carotid Plaque-Burden-Systematic COronary Risk EvaluationSystematic COronary Risk Evaluation2 (CPB-SCORE2) table compared to Systematic COronary Risk Evaluation2 (SCORE2) for MACE(12 year follow-up)

研究者

发起方
Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura
申办方类型
Other
责任方
Sponsor

相似试验